Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |